Kazia Therapeutics (KZIA) Net Income - Minority (2009)

Kazia Therapeutics (KZIA) reported Net Income - Minority of -$3.9 million for Q2 2009.

Kazia Therapeutics (KZIA) Net Income - Minority (2009) Analysis & Trends

Kazia Therapeutics has reported Net Income - Minority for 1 years, with the latest figure at -$3.9 million in Q2 2009.

For the quarter ending Q2 2009, Net Income - Minority changed N/A year-over-year to -$3.9 million; the trailing twelve-month figure through Jun 2009 stood at -$3.9 million (changed N/A YoY), and the FY2009 full-year result was -$3.8 million, changed N/A from the prior year.
Net Income - Minority for Q2 2009 stood at -$3.9 million.
The five-year high for Net Income - Minority was -$3.9 million in Q2 2009, with the low at -$3.9 million in Q2 2009.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income - Minority (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Kazia Therapeutics	1.70 Bn	1.70 Bn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2009	-3.87 Mn